Answers are grounded in this paper and cite their sources.
In our large observational cohort, use of tenofovir disoproxil fumarate (n=344) was associated with a greater decline in renal function than was use of alternative nucleoside analogues (n=314). Other associations included a lower CD4 cell count, decreased renal function at baseline, and diabetes. The declines were modest and did not lead to greater rates of discontinuation of therapy.
No takes yet. Share an insight, caveat, or question.
Gallant et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: